Myositis-specific autoantibodies and QTc changes by ECG in idiopathic inflammatory myopathies.

autoantibodies cardiac involvement electrocardiogram heart idiopathic inflammatory myopathy myositis

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
06 10 2022
Historique:
received: 22 07 2021
accepted: 27 12 2021
pubmed: 21 1 2022
medline: 12 10 2022
entrez: 20 1 2022
Statut: ppublish

Résumé

The aim of this study was to investigate cardiac involvement detected by ECG in patients with idiopathic inflammatory myopathies (IIMs) and to evaluate possible associations between the autoantibody profile and ECG changes in these patients. In a Scandinavian cross-sectional study, patients were included from two Danish centres and one Swedish centre. Resting 12-lead ECG was investigated in 261 patients with IIM compared with 102 patients with systemic sclerosis (SSc) and 48 healthy controls (HCs). ECG changes were correlated to clinical manifestations and myositis-specific and myositis-associated autoantibodies (MSAs and MAAs, respectively). Patients with IIM had a longer mean corrected QT (QTc) duration and more frequently presented with prolonged QTc (≥450 ms; P = 0.038) compared with HCs. A longer QTc duration was recorded in SSc compared with IIM [433 ms (s.d. 23) vs 426 (24); P = 0.011], yet there was no significant difference in the fraction with prolonged QTc (SSc: 22%, IIM: 16%; P = 0.19). In multivariable regression analyses, anti-Mi2 (P = 0.01, P = 0.035) and anti-Pl-7 (P = 0.045, P = 0.014) were associated with QTc duration and prolonged QTc in IIM. Elevated CRP was associated with prolonged QTc (P = 0.041). The presence of QTc abnormalities was as common in patients with IIM as in patients with SSc, including prolonged QTc seen in almost one-fifth of the patients. Anti-Mi2, anti-Pl-7 and elevated CRP may serve as biomarkers for cardiac disease in IIM, but needs to be confirmed in a larger prospective study.

Identifiants

pubmed: 35048961
pii: 6512046
doi: 10.1093/rheumatology/keac013
doi:

Substances chimiques

Autoantibodies 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4076-4086

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Sine Søndergaard Korsholm (SS)

Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
Department of Rheumatology, Odense University Hospital, Odense, Denmark.

Daniel C Andersson (DC)

Department of Physiology and Pharmacology, Karolinska Institute, Solna.
Heart, Vascular and Neurology Theme, Cardiology Unit, Karolinska University Hospital.

John Bonde Knudsen (JB)

Department of Rheumatology, Odense University Hospital, Odense, Denmark.

Maryam Dastmalchi (M)

Division of Rheumatology, Department of Medicine, Karolinska Institutet and Rheumatology, Solna, Karolinska University Hospital, Stockholm, Sweden.

Axel C P Diederichsen (ACP)

Department of Cardiology.

Oke Gerke (O)

Department of Nuclear Medicine, Odense University Hospital, Odense.

Nanna Witting (N)

Department of Neurology.

Søren Jacobsen (S)

Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen.

Redi Pecini (R)

Department of Cardiology, Copenhagen University Hospital.

Tina Friis (T)

Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.

Markus E Krogager (ME)

Department of Neurology.

Ingrid E Lundberg (IE)

Division of Rheumatology, Department of Medicine, Karolinska Institutet and Rheumatology, Solna, Karolinska University Hospital, Stockholm, Sweden.

Louise P Diederichsen (LP)

Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
Department of Rheumatology, Odense University Hospital, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH